🇺🇸 FDA

Company profile · Sponsor

DBV

DBV Technologies

ED969DE · EMA pharma EU
Pipeline
3
Drugs
0
Patents
0

Quick answer

DBV (ED969DE) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ED969DE
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (3)

Search pipeline →

  1. DBV712

    DBV

    Allergy, Peanut

    phase 3 small molecule active

    1 trial

  2. Peanut food challenge, oral paste “high dose” - 133.3 mg/g peanut proteins, Peanut food challenge, oral paste “placebo” - Placebo formulation, Soluprick Positive control, 10 mg/ml, Solution for skin-prick test, Viaskin Peanut, Soluprick Negative control, Solution for skin prick test, ALK 762 Jordnød, Opløsning til priktest (Soluprick), Nøddeallergen, The DBV712 Placebo Patch is the same system as DBV712 250 mcg Patch but without peanut proteins, Peanut food challenge, oral paste “low dose” - 6.6 mg/g peanut

    DBV

    Peanut allergy

    phase 3 small molecule active

    1 trial

  3. Peanut food challenge, oral paste “placebo” - Placebo formulation, Viaskin Peanut, Peanut food challenge, oral paste “low dose” - 6.6 mg/g peanut proteins, Peanut food challenge, oral paste “high dose” - 133.3 mg/g peanut proteins

    DBV

    Peanut allergy

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is DBV?

DBV (ED969DE) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does DBV sponsor?

We track 3 ClinicalTrials.gov-linked programs for DBV, including DBV712 and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does DBV company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.